"Drug Industry" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
That segment of commercial enterprise devoted to the design, development, and manufacture of chemical products for use in the diagnosis and treatment of disease, disability, or other dysfunction, or to improve function.
| Descriptor ID |
D004345
|
| MeSH Number(s) |
J01.576.655.750
|
| Concept/Terms |
Drug Industry- Drug Industry
- Industry, Pharmaceutic
- Industries, Pharmaceutic
- Pharmaceutic Industries
- Pharmaceutic Industry
- Industry, Drug
- Drug Industries
- Industries, Drug
- Industry, Pharmaceutical
- Industries, Pharmaceutical
- Pharmaceutical Industries
- Pharmaceutical Industry
|
Below are MeSH descriptors whose meaning is more general than "Drug Industry".
Below are MeSH descriptors whose meaning is more specific than "Drug Industry".
This graph shows the total number of publications written about "Drug Industry" by people in this website by year, and whether "Drug Industry" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2007 | 1 | 0 | 1 |
| 2009 | 1 | 0 | 1 |
| 2010 | 2 | 1 | 3 |
| 2011 | 2 | 0 | 2 |
| 2012 | 1 | 2 | 3 |
| 2013 | 4 | 0 | 4 |
| 2014 | 1 | 1 | 2 |
| 2016 | 3 | 2 | 5 |
| 2017 | 50 | 36 | 86 |
| 2018 | 28 | 27 | 55 |
| 2019 | 12 | 7 | 19 |
| 2020 | 18 | 20 | 38 |
| 2021 | 6 | 10 | 16 |
To return to the timeline, click here.
Below are the most recent publications written about "Drug Industry" by people in Profiles.
-
The pandemic and resilience for the future: AccBio 2021. Biotechnol Prog. 2022 01; 38(1):e3207.
-
Profiteering from vaccine inequity: a crime against humanity? BMJ. 2021 08 16; 374:n2027.
-
What are the obligations of pharmaceutical companies in a global health emergency? Lancet. 2021 09 11; 398(10304):1015-1020.
-
Rethinking Cancer Clinical Trial Conduct Induced by COVID-19: An Academic Center, Industry, Government, and Regulatory Agency Perspective. Cancer Discov. 2021 08; 11(8):1881-1885.
-
Sharing Technology and Vaccine Doses to Address Global Vaccine Inequity and End the COVID-19 Pandemic. JAMA. 2021 Jul 20; 326(3):219-220.
-
Understanding and predicting COVID-19 clinical trial completion vs. cessation. PLoS One. 2021; 16(7):e0253789.
-
Averting Future Vaccine Injustice. N Engl J Med. 2021 Jul 15; 385(3):193-196.
-
Development and validation of a predictive model to predict and manage drug shortages. Am J Health Syst Pharm. 2021 07 09; 78(14):1309-1316.
-
Preparing for the Next Normal: Transformation in the Role of Medical Affairs Following the COVID-19 Pandemic. Pharmaceut Med. 2021 07; 35(4):197-202.
-
Adopting medical technology: the case for a fast-tracked approach. Br J Hosp Med (Lond). 2021 Jul 02; 82(7):1-4.